The FDA granted priority review to sunvozertinib for the treatment of advanced NSCLC with EGFR exon 20 mutations, based on ...

Priority review granted for CUTX-101 with PDUFA target action date set for June 30, 2025 Cyprium is eligible to receive ...

Senate Republicans, waiting for their House counterparts to figure out their strategy on border security and tax reform, are ...

My Capital One Venture X comes with a free Priority Pass membership that gets me access to over 1,700 airport lounges, but ...

Zydus Lifesciences announces CVS Caremark agreement and FDA priority review for diabetes and Menkes disease treatments.

The NDA is supported by data from the open-label, single-center phase 1/2 90-CH-0149 trial and the open-label, single-arm phase 3 09-CH-0059 study.

Going out to eat? See which Marion County restaurants were rated best by inspectors, and which failed the test.

The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for avutometinib to be used in combination with defactinib for the treatment of adults with ...

Sentynl took over the therapy’s development and commercialisation from Fortress Biotech's subsidiary Cyprium Therapeutics.

Zydus Lifesciences rose 1.22% to Rs 974.75 after its wholly-owned subsidiary, Sentynl Therapeutics, and Fortress Biotech said that U.S. food and Drug Administration has accepted filing and priority ...

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application ...

Verastem (VSTM) said the FDA has accepted for priority review its application for accelerated approval of its ...